SIGN UPLog In

General

Financials

Investments
Co-Investors
Acquisitions
Exits

People

Founders
Employee Profiles

Activity

Recent News
bioMerieux
bioMerieux

Company

Investment-firm

Financing round

General

About Company
BioMerieux develops and produces in vitro diagnostic solutions for private and hospital laboratories.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1963

founders

Number of employees

101-250

Company Type

For Profit

IPO status

Private

Description

BioMérieux is a world leader in the field of in vitro diagnostics, with operations in Europe, the Middle East, Africa, North America, Asia-Pacific, and Latin America. The company operates in four segments: molecular biology, microbiology, immunoassays, and industrial applications. Its products are mainly used for diagnosing infectious diseases and detecting microorganisms in agri-food, pharmaceutical, and cosmetic products. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. BioMérieux is listed on the Euronext Paris stock market.
Contacts

location

69280 Marcy-l'Étoile, France

Phone number

Website URL

http://www.biomerieux.com

Social url

Similar Companies
1000
bioMérieux
bioMérieuxbioMérieux provides diagnostic solutions to improve patient health and ensure consumer safety.
bioMérieux

bioMérieux

bioMérieux provides diagnostic solutions to improve patient health and ensure consumer safety.

Sector

Medical Equipment and Services

Subsector

Medical Supplies

Location

50012 Bagno a Ripoli, Metropolitan City of Florence, Italy
Elitech Group
Elitech GroupELITechGroup manufactures and distributes diagnostic equipment and reagents to hospitals worldwide.
Elitech Group

Elitech Group

ELITechGroup manufactures and distributes diagnostic equipment and reagents to hospitals worldwide.

Sector

Medical Equipment and Services

Subsector

Medical Services

Location

Paris, France

total rounds

1
GenBio
GenBioGenBio is an experienced, fully integrated medical diagnostic company specializing in infectious disease and autoimmune disease diagnostics.
GenBio

GenBio

GenBio is an experienced, fully integrated medical diagnostic company specializing in infectious disease and autoimmune disease diagnostics.

Sector

Medical Equipment and Services

Subsector

Medical Supplies

Keywords

Health Diagnostics, Biotechnology, Health Care

Location

San Diego, CA, USA
Veravas
VeravasVeravas develops high-value solutions for accurate diagnosis of devastating diseases.
Veravas

Veravas

Veravas develops high-value solutions for accurate diagnosis of devastating diseases.

Sector

Medical Equipment and Services

Subsector

Medical Services

Keywords

Biotechnology, Health Care, Manufacturing

Location

Minnesota City, MN 55959, USA

total rounds

1

total raised

$4M

Financials

Investments
9
Date 
name 
Lead 
type 
Raised 
20.10.2023
Oxford Nanopore Technologies
Oxford Nanopore Technologies
Yes
Post-IPO Equity
$84.97M
Local Amount - GBP 70M
21.03.2023
Proxim Diagnostics
Proxim Diagnostics
Yes
Corporate Round
—
17.01.2023
InDevR
InDevR
Yes
Series B
$9M
Oxford Nanopore Technologies

Oxford Nanopore Technologies

Oxford Nanopore Technologies provides a novel generation of DNA/RNA sequencing technology that is fast, accessible, and easy to use.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Nanotechnology

Location

Oxford, UK

total rounds

20

total raised

$1.56B
Proxim Diagnostics

Proxim Diagnostics

Proxim Diagnostics develops a handheld immuno diagnostic device that performs important laboratory tests near the patient.

Sector

Medical Equipment and Services

Subsector

Medical Services

Location

Sunnyvale, CA, USA

total rounds

5

total raised

$22.9M
InDevR

InDevR

InDevR develops and manufactures microarray technologies and novel solutions for the life science industry.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Manufacturing, Life Science

Location

Boulder, CO, USA

total rounds

4

total raised

$19M
Co-Investors
Acquisitions
20
Acquiree Name 
Date 
Price 
Acquisition Name 
Invisible Sentinel
Invisible Sentinel
07.02.2019
$75M
bioMerieux-Invisible Sentinel
SuZhou Hybiome Biomedical Engineering
SuZhou Hybiome Biomedical Engineering
09.11.2018
—
bioMerieux-SuZhou Hybiome Biomedical Engineering
Astute Medical
Astute Medical
04.04.2018
—
bioMerieux-Astute Medical
Invisible Sentinel acquired by bioMerieux

Invisible Sentinel acquired by bioMerieux

acquirer

bioMerieux
bioMerieux

date

07.02.2019

type

Acquisition

price

$75M
Invisible Sentinel

Invisible Sentinel

Invisible Sentinel develops rapid diagnostic systems for detecting harmful pathogens in the food supply.

Sector

Medical Equipment and Services

Subsector

Medical Supplies

Keywords

Food and Beverage, Biotechnology, Health Diagnostics

Location

Philadelphia, PA, USA

total rounds

4

total raised

$17.64M
SuZhou Hybiome Biomedical Engineering acquired by bioMerieux

SuZhou Hybiome Biomedical Engineering acquired by bioMerieux

acquirer

bioMerieux
bioMerieux

date

09.11.2018

type

Acquisition
SuZhou Hybiome Biomedical Engineering

SuZhou Hybiome Biomedical Engineering

Hybiome Biomedical develops medical solutions for clinical diagnosis.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Medical Device, Health Care

Location

Suzhou, Jiangsu, China
Astute Medical acquired by bioMerieux

Astute Medical acquired by bioMerieux

acquirer

bioMerieux
bioMerieux

date

04.04.2018

type

Acquisition
Astute Medical

Astute Medical

Astute Medical identifies protein biomarkers for the diagnosis of high-risk medical conditions.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Life Science, Biotechnology

Location

San Diego, CA, USA

total rounds

9

total raised

$209.13M
Exits
1
AdvanDx
AdvanDxAdvanDx provides molecular diagnostic tests for identifying pathogens causing critical infections in hospitalized patients.
AdvanDx

AdvanDx

AdvanDx provides molecular diagnostic tests for identifying pathogens causing critical infections in hospitalized patients.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Woburn, MA, USA

total rounds

7

total raised

$49.7M

People

Founders
1

Alain Mérieux

organization founded

1
Alain Mérieux

Alain Mérieux

Employee Profiles
21
Grady Locknane
Grady Locknane

Grady Locknane

Corporate Account Executive- Vizient GPO

Corporate Account Executive- Vizient GPO

Jeff Townley
Jeff Townley

Jeff Townley

Director, Global IT Infrastructure Services

Director, Global IT Infrastructure Services

Carine Malcus-Vocanson
Carine Malcus-Vocanson

Carine Malcus-Vocanson

Director, Global Clinical Affairs ImmunoAssays, Molecular Biology and Global Bioethics compliance

Director, Global Clinical Affairs ImmunoAssays, Molecular Biology and Global Bioethics compliance

Frédéric Sweeney
Frédéric Sweeney

Frédéric Sweeney

Vice President, Corporate Development & Strategic Financing Lead

Vice President, Corporate Development & Strategic Financing Lead

Gregory Debuchy
Gregory Debuchy

Gregory Debuchy

Senior VP Global Supply Chain

Senior VP Global Supply Chain

Bob Korman
Bob Korman

Bob Korman

Manager, Center of Capabilities & Agility

Manager, Center of Capabilities & Agility

Bernard Gilly
Bernard Gilly

Bernard Gilly

SA and Vice President of Research and Development

SA and Vice President of Research and Development

Christopher Fitzgerald
Christopher Fitzgerald

Christopher Fitzgerald

Consultant

Consultant

Activity

Recent News
3
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month